“The LP Fault is one of the largest gold targets in Canada considering strike length and depth potential and it behooves us as a company to show what a discovery of this magnitude can deliver. Drilling is key to put meat on the bones. Exploration highlights are important, but showing continuity and grade over distance is the real target here.”
StemSynergy Therapeutics (SSTI) is a biotechnology company focused on discovering drugs that target biomolecules and cellular processes fundamental to cancer.
The Latin America Petrochemicals and Chemicals 2024 report, produced in alliance with APLA, explores the current state of these industries, the challenges they face, and the opportunities they offer.